Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a recently described form of amyloidosis that most frequently manifests clinically with progressive renal failure. In a series of 414 cases of amyloidosis, there were 40 cases of ALECT2: the second most common type of renal amyloidosis in this series. This was particularly common in Hispanic patients in the Southwest United States, where more than half of amyloidosis cases were ALECT2. It is possible that this represents a familial amyloidosis as there were two brothers with ALECT2 in our study. Morphologically, there was consistent amyloid deposition in the renal cortex with medullary involvement in only about a third of cases. There were no mutations detected in the LECT2 gene, although all patients tested were homozygous for the G nucleotide in a non-synonymous SNP at position 172. Most patients presented with chronic kidney disease and, on follow-up, showed progression with an average deterioration in renal function of 0.5 ml/min/1.73 m(2) per month. Unfortunately, the etiology of ALECT2 is currently unknown and there is currently no efficacious treatment of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2014.11DOI Listing

Publication Analysis

Top Keywords

leukocyte chemotactic
8
chemotactic factor
8
factor amyloidosis
8
amyloidosis cases
8
cases alect2
8
amyloidosis
7
renal
5
alect2
5
clinical morphologic
4
morphologic genetic
4

Similar Publications

Introduction: Granulocyte concentrates (GC) are leukocyte preparations enriched in neutrophils that can potentially save neutropenic patients from life-threatening, antimicrobial-resistant infections. The main challenge of GC transfusions is preserving the viability and antimicrobial activity of neutrophils beyond 24 h to reduce the logistical burden on collection centers and increase the availability of this cell therapy. Thus, the aim of this study was to explore extending the ex vivo viability and antimicrobial activity of GC neutrophils up to 72 h with a unique combination of the clinically-approved additives Plasma-Lyte, SAGM, AS-3 and Alburex.

View Article and Find Full Text PDF

Molecular cloning, expression analysis, and functional characterization of an interleukin-15 like gene in common carp ( L.).

Front Immunol

December 2024

Engineering Lab of Henan Province for Aquatic Animal Disease Control, College of Fisheries, Henan Normal University, Xinxiang, Henan, China.

Article Synopsis
  • Interleukin-15 (IL-15) is an important cytokine that regulates the immune system and is produced by various immune cells, playing a key role in the activation and survival of natural killer cells and CD8 T cells.
  • Researchers cloned and studied an IL-15 homologue called IL-15L in common carp, finding it expressed in multiple tissues, particularly in the intestine, and significantly increased during infections.
  • The study showed that overexpressing IL-15L enhanced immune responses, improved the activation of immune cells, and reduced bacterial loads in infected carp, suggesting its critical role in fish immunology.
View Article and Find Full Text PDF

Human B-cells can form Hetero-aggregates with Blood Platelets: A Novel Insight into Adaptive Immunity Regulation in Multiple Sclerosis.

J Mol Biol

November 2024

University of Lodz, Faculty of Biology and Environmental Protection, Department of General Biochemistry, Pomorska 141/143, 90-236 Lodz, Poland.

Article Synopsis
  • - Multiple sclerosis (MS) is an autoimmune disease that leads to inflammation and damage to nerve tissues, and this study investigates the interactions between blood platelets and immune cells (leukocytes) in MS patients.
  • - Researchers found that there is a significant increase in the movement of leukocytes towards platelets in MS, indicating that these immune interactions are enhanced, particularly in patients with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS).
  • - The study highlights the importance of the CD40-CD40L pathway in the communication between platelets and B-cells, suggesting that this interaction may play a key role in the progression of MS and could be a target for future therapeutic strategies.
View Article and Find Full Text PDF

Structural Basis for Chemerin Recognition and Signaling Through Its Receptors.

Biomedicines

October 2024

Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.

Chemerin is a chemotactic adipokine that participates in a multitude of physiological processes, including adipogenesis, leukocyte chemotaxis, and neuroinflammation. Chemerin exerts biological functions through binding to one or more of its G protein-coupled receptors (GPCRs), namely chemokine-like receptor 1 (CMKLR1), G protein-coupled receptor 1 (GPR1), and CC-motif receptor-like 2 (CCRL2). Of these receptors, CMKLR1 and GPR1 have been confirmed as signaling receptors of chemerin, whereas CCRL2 serves as a chemerin-binding protein without transmembrane signaling.

View Article and Find Full Text PDF

Immune traits in combination with inflammatory proteins revealing the pathogenesis of autoimmune liver diseases: A Mendelian randomization study.

Cytokine

January 2025

Department of Surgical, Hebei Medical University, Shijiazhuang 050017, China.; Department of Hand & Foot Surgery, First Hospital of Qinhuangdao, Qinhuangdao 066000, China.. Electronic address:

Background: Prior observational research has shown relationships between immune cells, inflammatory proteins, and autoimmune liver diseases (AILD), but their causal associations remain controversial. Therefore, we aimed to clarify the causal association between them.

Methods: We carried out a comprehensive Mendelian randomization (MR) analysis to clarify causal associations between 731 immune traits, 91 circulating inflammatory proteins, and AILD, including primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!